ZMIZ2 facilitates hepatocellular carcinoma progression via LEF1 mediated activation of Wnt/β-catenin pathway

Table 1 Correlation of clinicopathologic characteristics and ZMIZ2 in TCGA-LIHC cohort

Characteristics	N	Percent (%)	ZMIZ2 level		P Chi squared test
Characteristics	N	Percent (%)	Low	High	P Chi squared test
Total cases	369	100	184	185
Gender					0.683
Male	249	67.48	126	123
Female	120	32.52	58	62
Age					0.754
< 60	169	45.80	86	98
≥ 60	199	53.93	98	101
Clinical stage					0.056
I	171	46.34	96	75
II	86	23.31	38	48
III	83	22.49	35	48
IV	5	1.36	4	1
Pathology T stage					0.060
T1	181	49.05	101	80
T2	94	25.47	40	54
T3	78	21.14	35	43
T4	13	3.52	5	8
Tx			3	0
Pathology N stage					1
N0	250	67.75	125	125
N1	4	1.08	2	2
Pathology grade					0.020*
G1-2	232	62.87	126	106
G3-4	132	35.77	55	77
Vascular invasion					0.620
None	206	55.83	114	92
Micro	93	25.20	46	47
Macro	14	3.79	7	7

ISSN: 2162-3619